In lung tissues of pulmonary hypertension rodent models, B cell activation and immunoglobulin E (IgE) production lead to mast cell activation and release of the cytokines IL-6 and IL-13, which result in remodeling of vascular smooth muscle cells. Blockade of IgE with omalizumab, a clinically approved monoclonal antibody against IgE, alleviated the progression of experimental pulmonary hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Shu, T., Xing, Y. & Wang, J. Autoimmunity in pulmonary arterial hypertension: evidence for local immunoglobulin production. Front. Cardiovasc. Med. 8, 680109 (2021). A Review that presents the adaptive immune response in lungs with PAH.
Guo, J. et al. Allergic asthma is a risk factor for human cardiovascular diseases. Nat. Cardiovasc. Res. 1, 417–430 (2022). A Review on the role of IgE in cardiovascular diseases.
Daley, E. et al. Pulmonary arterial remodeling induced by a Th2 immune response. J. Exp. Med. 205, 361–372 (2008). A paper that reports pulmonary vascular remodeling in mice with ovalbumin-induced asthma.
Dib, H. et al. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur. Respir. J. 39, 1405–1414 (2012). A paper that reports autoantigens in pulmonary endothelial cells in PAH.
Xu, Z. et al. The relationship of serum antigen-specific and total immunoglobulin E with adult cardiovascular diseases. Int. J. Med. Sci. 15, 1098–1104 (2018). A paper that reports the relationship between antigen-specific IgE and cardiovascular diseases.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Shu, T. et al. Inhibition of immunoglobulin E attenuates pulmonary hypertension. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00095-9 (2022).
Rights and permissions
About this article
Cite this article
IgE promotes pulmonary hypertension through mast cell–derived IL-6 and IL-13. Nat Cardiovasc Res 1, 609–610 (2022). https://doi.org/10.1038/s44161-022-00104-x
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s44161-022-00104-x
